Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Cytomegalovirus Infection

  Free Subscription


Articles published in Transplant Proc

Retrieve available abstracts of 39 articles:
HTML format
Text format



Single Articles


    January 2018
  1. BARADHI KM, Aure RL, El-Amm JM
    High-dose Valganciclovir Treatment for Resistant Cytomegalovirus Colitis due to UL97 and UL54 Mutations.
    Transplant Proc. 2018;50:142-144.
    PubMed     Text format     Abstract available


  2. NANMOKU K, Shinzato T, Kubo T, Shimizu T, et al
    Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative Kidney Transplant Recipients Using Low-Dose Valganciclovir.
    Transplant Proc. 2018;50:124-129.
    PubMed     Text format     Abstract available


    December 2017
  3. HALLECK F, Khadzhynov D, Schrezenmeier E, Lehner L, et al
    Prolonged Low-Dose Prophylaxis With Valganciclovir in Cytomegalovirus-Negative Recipients of Kidney Transplants From Cytomegalovirus-Positive Donors Allows Seroconversion and Prevents Cytomegalovirus Disease.
    Transplant Proc. 2017;49:2280-2284.
    PubMed     Text format     Abstract available


    October 2017
  4. KAYA AH, Tekgunduz E, Akpinar S, Batgi H, et al
    Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting?
    Transplant Proc. 2017;49:1911-1915.
    PubMed     Text format     Abstract available


  5. FAVI E, Santangelo R, Iesari S, Morandi M, et al
    Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience.
    Transplant Proc. 2017;49:1766-1772.
    PubMed     Text format     Abstract available


    September 2017
  6. ECHENIQUE IA, Beltran D, Ramirez-Ruiz L, Najafian N, et al
    Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report.
    Transplant Proc. 2017;49:1560-1564.
    PubMed     Text format     Abstract available


    June 2017
  7. BRUMINHENT J, Rotjanapan P, Watcharananan SP
    Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Transplant Proc. 2017;49:1048-1052.
    PubMed     Text format     Abstract available


  8. HARADA S, Nakamura T, Ushigome H, Akutsu N, et al
    Beneficial Effects of High-Dose Mizoribine on ABO-Incompatible Living-Related Kidney Transplantation: Two-Year Results by a Japanese Multicenter Study.
    Transplant Proc. 2017;49:967-970.
    PubMed     Text format     Abstract available


    May 2017
  9. BRASIL IRC, Custodio-Lima J, Sampaio RL, Pierre AMM, et al
    Pre-emptive Therapy for Cytomegalovirus in Post-transplantation Liver Patients With Donor-Positive/Recipient-Negative Serostatus.
    Transplant Proc. 2017;49:871-873.
    PubMed     Text format     Abstract available


  10. PRETAGOSTINI R, Poli L, Lai Q, Russo G, et al
    Pre-Emptive Therapy for the Treatment of Cytomegalovirus After Kidney Transplantation.
    Transplant Proc. 2017;49:638-641.
    PubMed     Text format     Abstract available


  11. PULITI REIGADA CH, de Ataide EC, de Almeida Prado Mattosinho T, Boin IFSF, et al
    Hepatic Artery Thrombosis After Liver Transplantation: Five-Year Experience at the State University of Campinas.
    Transplant Proc. 2017;49:867-870.
    PubMed     Text format     Abstract available


    April 2017
  12. KIR O, Zeytinoglu A, Arda B, Yilmaz M, et al
    Impact of Prophylaxis vs Pre-emptive Approach for Cytomegalovirus Infection in Kidney Transplant Recipients.
    Transplant Proc. 2017;49:537-540.
    PubMed     Text format     Abstract available


    March 2017
  13. RUAN V, Czer LS, Awad M, Kittleson M, et al
    Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review.
    Transplant Proc. 2017;49:253-259.
    PubMed     Text format     Abstract available


    January 2017
  14. SHI Y, Liu H, Chen XG, Shen ZY, et al
    Comparison of Mizoribine and Mycophenolate Mofetil With a Tacrolimus-Based Immunosuppressive Regimen in Living-Donor Kidney Transplantation Recipients: A Retrospective Study in China.
    Transplant Proc. 2017;49:26-31.
    PubMed     Text format     Abstract available


    November 2016
  15. LUNA E, Caravaca F, Ferreira F, Fernandez N, et al
    Effect of Cytomegalovirus Infection on Survival of Older Kidney Transplant Patients (D+/R+): Impact of Valganciclovir Prophylaxis Versus Preemptive Therapy.
    Transplant Proc. 2016;48:2931-2937.
    PubMed     Text format     Abstract available


  16. CARBONE J, Gallego A, Fernandez Yanez J, Sousa I, et al
    Potential Immunomodulatory Role of Specific Anticytomegalovirus Intravenous Immunoglobulin in Heart Recipients.
    Transplant Proc. 2016;48:3027-3029.
    PubMed     Text format     Abstract available


    October 2016
  17. FENG S, Yang J, Wang W, Hu X, et al
    Incidence and Risk Factors for Cytomegalovirus Infection in Patients With Kidney Transplantation: A Single-Center Experience.
    Transplant Proc. 2016;48:2695-2699.
    PubMed     Text format     Abstract available


    July 2016
  18. FAYEK SA, Beshears E, Lieber R, Alvey N, et al
    Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease.
    Transplant Proc. 2016;48:2056-2064.
    PubMed     Text format     Abstract available


    June 2016
  19. TARASEWICZ A, Debska-Slizien A, Rutkowski B
    Clinical Utility of QuantiFERON-Cytomegalovirus Test in Management of Kidney Transplant Recipients.
    Transplant Proc. 2016;48:1650-3.
    PubMed     Text format     Abstract available


    May 2016
  20. KANG GW, Hong HL, Lee IH, Ahn KS, et al
    Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report.
    Transplant Proc. 2016;48:1208-11.
    PubMed     Text format     Abstract available


  21. MATSUURA R, Maeda A, Sakai R, Eguchi H, et al
    Human HLA-Ev (147) Expression in Transgenic Animals.
    Transplant Proc. 2016;48:1323-5.
    PubMed     Text format     Abstract available


    April 2016
  22. NAGANUMA T, Takemoto Y, Iwai T, Kuwabara N, et al
    Effects of Granulocyte and Monocyte Adsorptive Apheresis in Renal Transplantation Recipients With Concomitant Cytomegalovirus Infection.
    Transplant Proc. 2016;48:929-32.
    PubMed     Text format     Abstract available


  23. IWAMOTO H, Nakamura Y, Konno O, Tomita K, et al
    Immunosuppressive Therapy for Elderly Kidney Transplant Recipients.
    Transplant Proc. 2016;48:799-801.
    PubMed     Text format     Abstract available


  24. USHIGOME H, Uchida K, Nishimura K, Akioka K, et al
    Efficacy and Safety of High-Dose Mizoribine Combined With Cyclosporine, Basiliximab, and Corticosteroids in Renal Transplantation: A Japanese Multicenter Study.
    Transplant Proc. 2016;48:794-8.
    PubMed     Text format     Abstract available


    March 2016
  25. AMBROSE T, Sharkey LM, Louis-Auguste J, Rutter CS, et al
    Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation.
    Transplant Proc. 2016;48:492-6.
    PubMed     Text format     Abstract available


  26. ARZE S, Arze L, Abecia C
    Post-transplantation Infections in Bolivia.
    Transplant Proc. 2016;48:646-53.
    PubMed     Text format     Abstract available


    October 2015
  27. CHIASAKUL T, Townamchai N, Jutivorakool K, Chancharoenthana W, et al
    Risk Factors of Cytomegalovirus Disease in Kidney Transplant Recipients: A Single-Center Study in Thailand.
    Transplant Proc. 2015;47:2460-4.
    PubMed     Text format     Abstract available


    July 2015
  28. MADI N, Al-Qaser M, Edan R, Al-Nakib W, et al
    Clinical Utility of Viral Load in the Management of Cytomegalovirus Infection in Solid Organ Transplant Patients in Kuwait.
    Transplant Proc. 2015;47:1802-7.
    PubMed     Text format     Abstract available


  29. SANTOS CA, Brennan DC, Olsen MA
    Accuracy of Inpatient International Classification of Diseases, Ninth Revision, Clinical Modification Coding for Cytomegalovirus After Kidney Transplantation.
    Transplant Proc. 2015;47:1772-6.
    PubMed     Text format     Abstract available


    June 2015
  30. YALCI A, Celebi ZK, Ozbas B, Sengezer OL, et al
    Evaluation of Infectious Complications in the First Year After Kidney Transplantation.
    Transplant Proc. 2015;47:1429-32.
    PubMed     Text format     Abstract available


  31. KELES Y, Tekin S, Duzenli M, Yuksel Y, et al
    Post-transplantation Malignancy After Kidney Transplantation in Turkey.
    Transplant Proc. 2015;47:1418-20.
    PubMed     Text format     Abstract available


    May 2015
  32. JAVAD HOSSEINI SM, Nemati E, Behzadian F, Einollahi B, et al
    Evaluation of ganciclovir resistance in cytomegalovirus infection of renal transplant recipients in tehran.
    Transplant Proc. 2015;47:1140-2.
    PubMed     Text format     Abstract available


  33. ESHRAGHI H, Hekmat R
    Which CMV viral load threshold should be defined as CMV infection in kidney transplant patients?
    Transplant Proc. 2015;47:1136-9.
    PubMed     Text format     Abstract available


    January 2015
  34. MILINKOVIC M, Jovicic-Pavlovic S, Lausevic M, Durutovic O, et al
    Epidemic varicella zoster virus reactivation in renal transplant recipients: a case report.
    Transplant Proc. 2015;47:146-50.
    PubMed     Text format     Abstract available


  35. GARCIA-PAJARES F, Santos-Santamarta F, Fernandez-Fontecha E, Sanchez-Ocana R, et al
    Severe anemia, gastric ulcer, pneumonitis and cholangitis in a liver transplant patient: multiple organic dysfunction and one etiology: a case report.
    Transplant Proc. 2015;47:136-8.
    PubMed     Text format     Abstract available


    December 2014
  36. SMITH A, Couvillion R, Zhang R, Killackey M, et al
    Incidence and management of leukopenia/neutropenia in 233 kidney transplant patients following single dose alemtuzumab induction.
    Transplant Proc. 2014;46:3400-4.
    PubMed     Text format     Abstract available


    September 2014
  37. QUAGLIA M, Cena T, Fenoglio R, Musetti C, et al
    Immune function assay (immunknow) drop over first 6 months after renal transplant: a predictor of opportunistic viral infections?
    Transplant Proc. 2014;46:2220-3.
    PubMed     Text format     Abstract available


  38. SILVESTRE C, Furian L, Marson P, Tison T, et al
    Desensitization With Plasmapheresis and Anti-Cd20 for ABO Incompatible Kidney Transplantation From Living Donor: Experience of a Single Center in Italy.
    Transplant Proc. 2014;46:2209-13.
    PubMed     Text format     Abstract available


    July 2014
  39. LAFTAVI MR, Pankewycz O, Gruessner A, Brian M, et al
    Long-term outcomes of pancreas after kidney transplantation in small centers: is it justified?
    Transplant Proc. 2014;46:1920-3.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: